BiondVax Pharmaceuticals Financials
| BVXVDelisted Stock | USD 0.93 0.01 1.09% |
With this module, you can analyze BiondVax financials for your investing period. You should be able to track the changes in BiondVax Pharmaceuticals individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
BiondVax |
Understanding current and past BiondVax Pharmaceuticals Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of BiondVax Pharmaceuticals' financial statements are interrelated, with each one affecting the others. For example, an increase in BiondVax Pharmaceuticals' assets may result in an increase in income on the income statement.
The data published in BiondVax Pharmaceuticals' official financial statements usually reflect BiondVax Pharmaceuticals' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of BiondVax Pharmaceuticals. For example, before you start analyzing numbers published by BiondVax accountants, it's critical to develop an understanding of what BiondVax Pharmaceuticals' liquidity, profitability, and earnings quality are in the context of the Pharmaceuticals space in which it operates.
Please note, the presentation of BiondVax Pharmaceuticals' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, BiondVax Pharmaceuticals' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in BiondVax Pharmaceuticals' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of BiondVax Pharmaceuticals. Please utilize our Beneish M Score to check the likelihood of BiondVax Pharmaceuticals' management manipulating its earnings.
BiondVax Pharmaceuticals Stock Summary
BiondVax Pharmaceuticals competes with First Wave, Salarius Pharmaceuticals, SAB Biotherapeutics, Vaccinex, and GeoVax Labs. BiondVax Pharmaceuticals Ltd., a development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious diseases and other illnesses in Israel. The company was incorporated in 2003 and is headquartered in Jerusalem, Israel. Biondvax Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 15 people.| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| ISIN | US09073Q1058 |
| Business Address | Jerusalem BioPark Building, |
| New Symbol | SCNI |
| Sector | Pharmaceuticals |
| Industry | Health Care |
| Benchmark | NYSE Composite |
| Website | www.biondvax.com |
| Phone | 972 8 930 2529 |
| Currency | USD - US Dollar |
You should never invest in BiondVax Pharmaceuticals without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of BiondVax Stock, because this is throwing your money away. Analyzing the key information contained in BiondVax Pharmaceuticals' financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
BiondVax Pharmaceuticals Key Financial Ratios
Generally speaking, BiondVax Pharmaceuticals' financial ratios allow both analysts and investors to convert raw data from BiondVax Pharmaceuticals' financial statements into concise, actionable information that can be used to evaluate the performance of BiondVax Pharmaceuticals over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that BiondVax Pharmaceuticals reports annually and quarterly.| Return On Equity | -56.02 | |||
| Return On Asset | -0.31 | |||
| Target Price | 39.0 |
BiondVax Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining BiondVax Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare BiondVax Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across BiondVax Pharmaceuticals competition to find correlations between indicators driving BiondVax Pharmaceuticals's intrinsic value. More Info.BiondVax Pharmaceuticals is rated below average in return on equity category among related companies. It is rated below average in return on asset category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value BiondVax Pharmaceuticals by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for BiondVax Pharmaceuticals' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the BiondVax Pharmaceuticals' earnings, one of the primary drivers of an investment's value.BiondVax Pharmaceuticals Market Pulse
| Quote | 0.93 |
| Change(%) | 1.09 |
| Change | 0.01 |
| Open | 0.92 |
| Low | 0.92 |
| High | 0.97 |
| Volume | 0 |
| Exchange | NASDAQ |
About BiondVax Pharmaceuticals Financials
What exactly are BiondVax Pharmaceuticals Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include BiondVax Pharmaceuticals' income statement, its balance sheet, and the statement of cash flows. Potential BiondVax Pharmaceuticals investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although BiondVax Pharmaceuticals investors may use each financial statement separately, they are all related. The changes in BiondVax Pharmaceuticals's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on BiondVax Pharmaceuticals's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.Steps to analyze BiondVax Pharmaceuticals Financials for Investing
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as BiondVax Pharmaceuticals is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of BiondVax has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it. In summary, you can determine if BiondVax Pharmaceuticals' financials are consistent with your investment objective using the following steps:- Review BiondVax Pharmaceuticals' balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
- Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
- Study the cash flow inflows and outflows to understand BiondVax Pharmaceuticals' liquidity and solvency.
- Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
- Compare BiondVax Pharmaceuticals' financials to those of its peers to see how it stacks up and identify any potential red flags.
- Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if BiondVax Pharmaceuticals' stock is overvalued or undervalued.
BiondVax Pharmaceuticals April 23, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of BiondVax Pharmaceuticals help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of BiondVax Pharmaceuticals. We use our internally-developed statistical techniques to arrive at the intrinsic value of BiondVax Pharmaceuticals based on widely used predictive technical indicators. In general, we focus on analyzing BiondVax Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build BiondVax Pharmaceuticals's daily price indicators and compare them against related drivers.
| Information Ratio | (0.17) | |||
| Maximum Drawdown | 26.71 | |||
| Value At Risk | (7.00) | |||
| Potential Upside | 4.26 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Consideration for investing in BiondVax Stock
If you are still planning to invest in BiondVax Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the BiondVax Pharmaceuticals' history and understand the potential risks before investing.
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |